SOLICITATION NOTICE
66 -- Telemetry Scientific Device
- Notice Date
- 6/21/2018
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, Clinical Center/Office of Purchasing & Contracts, 6707 Democracy Blvd, Suite 106, MSC 5480, Bethesda, Maryland, 20892-5480
- ZIP Code
- 20892-5480
- Solicitation Number
- 18-012319
- Archive Date
- 7/5/2018
- Point of Contact
- Priscilla S. Abalos, Phone: 3015943879
- E-Mail Address
-
priscilla.abalos@nih.gov
(priscilla.abalos@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH), Clinical Center (CC), Office of Purchasing and Contracts (OPC) on behalf of the Nutrition Department, Clinical Center (CC) at the National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to: NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE: The Intended procurement is classified under NAICS code 334519 with a Size Standard 1000 # of Employees. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2005-96 May 31, 2018. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($150,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION 1. Title: Telemetry Scientific Device 2. Background Information: The Critical Care Medicine Department (CCMD) was established in November 1977 to provide medical care for critically ill patients throughout the Clinical Center who have potentially reversible medical problems. Critical care medicine may be defined as the observation, diagnosis, treatment, and rehabilitation of patients with overt or potential failure of vital functions. The Department is currently composed of the following sections: • Clinical Medical Services • Critical Care Therapy and Respiratory Care • Research Section • AIDS Section • Administrative Services CCMD Mission :To provide high quality and cost effective clinical service that meets the needs of CC patients and NIH Institutes, to facilitate the research goals of NIH Institutes and investigators, and to conduct high quality research and training in Critical Care Medicine. CCMD Research Section The Critical Care Medicine Department conducts active research programs in bedside clinical investigation, research in animal models, and molecular biology. Full-time research activities commence at the beginning of the second year of the fellowship for fellows interested in the critical care subspecialty alone. For those interested in dual board eligibility, their second-year program is individually designed and consists of clinical rotations required for board eligibility in the particular subspecialties. After completion of second subspecialty training, full-time research activities commence. Major topics of research interest within the Department include: • The immunopathogenesis of septic shock • Studies of immune cellular function in respiratory distress syndrome, asthma, and other forms of severe pulmonary disease • Biomarkers and novel therapies in pulmonary arterial hypertension • Biomarkers of acute cellular rejection in heart transplantation • Diagnosis and treatment of opportunistic infections • Studies of immune cellular function and therapy of AIDS • Pathogenesis and treatment of anthrax • Emerging infectious diseases • Biology and clinical effects of nitric oxide o acute lung injury o pulmonary arterial hypertension o role as transcription regulatory factor • Functional genomics of critical illness o human acute inflammation o animal model of septic shock and multiple organ failure o pulmonary arterial hypertension o solid organ transplantation o Emerging Infectious Disease o Pneumocystis 3. Purpose: Rhesus macaques have been shown to be naturally infected by ZIKV in a manner similar to human infection (Younger, 2016) and exhibit clinical symptoms of viremia that closely mimic human symptoms of infection and result in viremia in multiple body fluids (Osuna, 2016). ZIKV infection of pregnant macaques results in fetal brain anomalies that closely mimic the observed effects in humans (Waldrof, 2016). Macaque monkeys (Macaca spp.) have also been shown to be good models for human reproduction due to genetic overlap, placental morphology (Cater, 2007), the singleton nature of birth, and the comparable levels of developmental maturity at birth (Stolte, 1975). The request the purchase of implantable telemetry devices from Data Science International (DSI). DSI is the sole manufacturer of DSI technology for physiologic monitoring platforms, associated software and devices for all species. Objectives: 1. Evaluate diagnostic and prognostic value of early biomarkers of fetal neurological injury in maternal serum. 2. Evaluate diagnostic and prognositic value of ultrasound and MRI imaging during gestation and postnatally. 3.Characterize ZIKV pathogeneisis during gestation and postnatally following early versus late trimester infection. CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME) DETERMINATION The intended sole source is the only known source to meet the technical needs of the scientific equipment/supplies. The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted as prescribed in FAR Part 10-Market Research. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by June 28, 2018 at 9:00 AM Eastern time and must reference solicitation number 18-003649. Responses may be submitted electronically to Priscilla Abalos, Contracting Specialist at Priscilla.abalos@nih.gov. Fax responses will not be accepted. "All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency."
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/CCOPC/18-012319/listing.html)
- Place of Performance
- Address: National Institute of Health, 9000 Rockville Pike, bldg. 10 Room 4 D-03, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN04963797-W 20180623/180621231248-2bc315dbe12f49da10f776e16a3b11ec (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |